Bipolar Disorder antibodies

and ELISA kits, proteins related to Bipolar Disorder.

Introduction to Bipolar Disorder

Bipolar Disorder is a complex mental health condition characterized by extreme mood swings, including emotional highs (mania or hypomania) and lows (depression). These fluctuations can affect energy levels, behavior, and the ability to carry out daily tasks, impacting individuals' personal and professional lives. Recent research has begun to uncover the role of the immune system in Bipolar Disorder, particularly focusing on antibodies that may influence brain function and mood regulation. Understanding the connection between antibodies and Bipolar Disorder opens new avenues for targeted treatments and improved management strategies. By exploring these advanced scientific insights, we aim to enhance the lives of those affected and pave the way for innovative therapies that address the root causes of this challenging condition.

Bipolar Disorder biomarkers

M00791

Anti-GSK3 beta Rabbit Monoclonal Antibody, Immunofluorescent analysis using the Antibody at 1:50 dilution....

PB9438

Anti-Serotonin transporter/SLC6A4 Antibody Picoband®, IF analysis of SLC6A4 using anti-SLC6A4 antibody (PB9438).
SLC6A4 was detected in paraffin-embedded section of mous...

RP1082

Anti-KAT13D/CLOCK Antibody Picoband®, IF analysis of KAT13D/CLOCK using anti-KAT13D/CLOCK antibody (RP1082) and anti-Tubulin Alpha antibody (M03989-3).
KAT13D/CLOCK was detected i...

Protein Name	Gene Name	Function
BDNF	BDNF	Brain-derived neurotrophic factor involved in neuroplasticity.
GSK3β	GSK3B	Glycogen synthase kinase 3 beta involved in mood regulation and circadian rhythms.
CACNA1C	CACNA1C	Calcium channel subunit involved in calcium signaling and neuronal function.
DISC1	DISC1	Disrupted in Schizophrenia 1 involved in neuronal development and synaptic function.
ANK3	ANK3	Ankyrin 3 involved in neuronal membrane stability and signal transduction.
SLC6A4	SLC6A4	Serotonin transporter involved in serotonin reuptake in the synaptic cleft.
COMT	COMT	Catechol-O-Methyltransferase involved in the metabolism of dopamine and other catecholamines.
NR1	GRIN1	NMDA receptor subunit involved in glutamate neurotransmission.
CLOCK	CLOCK	Circadian Locomotor Output Cycles Kaput involved in regulating circadian rhythms.
IL-6	IL6	Interleukin 6 involved in inflammatory responses.
TNF-α	TNF	Tumor Necrosis Factor Alpha involved in systemic inflammation.
FABP7	FABP7	Fatty Acid Binding Protein 7 involved in lipid transport in the brain.
VEGF	VEGFA	Vascular Endothelial Growth Factor involved in angiogenesis and neurogenesis.
CRP	CRP	C-Reactive Protein a marker of general inflammation.
MAPK	MAPK3	Mitogen-Activated Protein Kinase involved in cell signaling pathways.
AKT1	AKT1	AKT Serine/Threonine Kinase 1 involved in intracellular signaling related to mood regulation.
NTRK2	NTRK2	Neurotrophic Receptor Tyrosine Kinase 2 receptor for BDNF involved in neural survival and plasticity.
MECP2	MECP2	Methyl CpG Binding Protein 2 involved in gene regulation and neuronal function.
FGF2	FGF2	Fibroblast Growth Factor 2 involved in neurodevelopment and neuroprotection.
BDNF Val66Met	BDNF	A polymorphism in BDNF affecting its activity-dependent secretion and neuronal function.

Important Mechanisms

Neurobiological Mechanisms

Neurobiological mechanisms are pivotal in understanding Bipolar Disorder, focusing on the structural and functional aspects of the brain that contribute to the disorder's manifestation. Research in this area explores neurotransmitter imbalances, particularly involving serotonin, dopamine, and norepinephrine, which play crucial roles in mood regulation. Advanced neuroimaging techniques, such as MRI and PET scans, have revealed differences in brain regions like the prefrontal cortex, amygdala, and hippocampus among individuals with Bipolar Disorder compared to healthy controls. Additionally, studies investigate neuronal connectivity and synaptic plasticity, shedding light on how disruptions in these processes may lead to the cyclical mood swings characteristic of the disorder. Understanding the neurobiological underpinnings not only aids in elucidating the pathophysiology of Bipolar Disorder but also informs the development of targeted pharmacological treatments that can more effectively stabilize mood and mitigate symptoms.

Genetic Factors

Genetic factors are fundamental in the study of Bipolar Disorder, as evidenced by the significant heritability estimates observed in family and twin studies. Research in this sub-area seeks to identify specific genetic variants and patterns that increase susceptibility to the disorder. Genome-wide association studies (GWAS) have uncovered several risk loci that may influence the likelihood of developing Bipolar Disorder, highlighting genes involved in neurotransmission, circadian rhythms, and neuroplasticity. Additionally, investigations into gene-environment interactions examine how genetic predispositions may interact with external stressors or lifestyle factors to trigger the onset of the disorder. Understanding the genetic architecture of Bipolar Disorder not only enhances our comprehension of its etiology but also paves the way for personalized medicine approaches. By identifying genetic markers, clinicians can better predict disease risk, tailor preventive strategies, and customize treatment plans to improve therapeutic outcomes for individuals affected by Bipolar Disorder.